BioNet at MSS2026
BioNet is pleased to participate in MSS2026, the next-gen bioManufacturing & delivery Science Symposium, taking place from 14-16 September 2026 in Bled, Slovenia. The symposium brings together scientists, researchers, and industry leaders to discuss the latest advances in biopharmaceutical manufacturing, delivery systems, and analytical technologies for vaccines, gene therapies, and other biological products.
Representing BioNet, Mukesh Chauhan, Director Production, will present”Evolution of Vaccine Technologies: From Recombinant Vaccines to pDNA and mRNA Platforms” on 15 September 2026 as part of the Nucleic Acids and LNPs stream. The presentation will explore the progression of vaccine technologies and share BioNet’s experience in advancing vaccine platforms, from recombinant vaccines to DNA and mRNA-based approaches.
Presentation Highlights
- Speaker: Mukesh Chauhan, Director Production, BioNet
- Presentation: Evolution of Vaccine Technologies: From Recombinant Vaccines to pDNA and mRNA Platforms
- Date: Tuesday, 15 September 2026
- Time: 3:15 – 3:40 PM
- Track: Nucleic Acids and LNPs
- Location: Bled, Slovenia
If you are attending MSS2026 and would like to connect with us to learn more about our vaccine technologies and platforms, please contact us at [email protected]
MSS2026 provides a valuable platform for collaboration and knowledge exchange across the biopharmaceutical sector. BioNet is proud to contribute to this international scientific forum and share its perspective on the continued evolution of vaccine innovation and manufacturing excellence.
Learn more about MSS2026
